Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL FACIAL AESTHETICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL FACIAL AESTHETICS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL FACIAL AESTHETICS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
6.1 PRICE IMPACT
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 STRATEGIC DECISION FOR MANUFACTURER/SERVICE PROVIDER
7 INDUSTRY INSIGHTS
8 GLOBAL FACIAL AESTHETICS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 BOTOX INJECTION
8.2.1 BY TYPE
8.2.1.1. NATURAL
8.2.1.1.1. HYALURONIC ACID LIP FILLER
8.2.1.1.2. SINGLE-PHASE
8.2.1.1.3. DUPLEX-PHASE
8.2.1.1.4. FAT INJECTION OR LIPOINJECTION
8.2.1.1.5. LIP COLLAGEN INJECTIONS
8.2.1.1.6. PLATELET-RICH PLASMA (PRP)
8.2.1.1.7. OTHERS
8.2.1.2. SYNTHETIC
8.2.1.2.1. POLY-L-LACTIC ACID LIP FILLERS
8.2.1.2.2. CALCIUM HYDROXYLAPATITE
8.2.1.2.3. POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)
8.2.1.2.4. POLYALKYLIMIDE
8.2.1.2.5. POLYACRYLAMIDE (PA)
8.2.1.2.6. OTHERS
8.2.2 BY DRUG TYPE
8.2.2.1. BRANDS
8.2.2.1.1. JUVEDERM
8.2.2.1.2. SCULPTRA
8.2.2.1.3. RADIESSE
8.2.2.1.4. RESTYLANE
8.2.2.1.5. ZYPLAST
8.2.2.1.6. BELLAFILL
8.2.2.1.7. PURAGEN
8.2.2.1.8. ELEVESS
8.2.2.1.9. AQUAMID
8.2.2.2. GENERIC
8.3 DERMAL FILLERS
8.3.1 NATURAL DERMAL FILLERS
8.3.2 SYNTHETIC DERMAL FILLERS
8.4 COLLAGEN INJECTIONS
8.5 CHEMICAL PEEL
8.5.1 SUPERFICIAL PEEL
8.5.2 MEDIUM PEEL
8.5.3 DEEP PEEL
8.6 FACIAL TONING
8.7 FRAXEL
8.8 COSMETIC ACUPUNCTURE
8.9 ELECTROTHERAPY
8.1 MICRODERMABRASION
8.11 CREAM
8.12 ENERGY DEVICES
8.13 OTHERS
9 GLOBAL FACIAL AESTHETICS MARKET, BY DRUG TYPE
9.1 BRANDED
9.1.1 JUVEDERM
9.1.2 SCULPTRA
9.1.3 RADIESSE
9.1.4 RESTYLANE
9.1.5 ZYPLAST
9.1.6 BELLAFILL
9.1.7 PURAGEN
9.1.8 ELEVESS
9.1.9 OTHERS
9.2 GENERIC
10 GLOBAL FACIAL AESTHETICS MARKET, BY USABILITY
10.1 PROFESSIONAL USE
10.1.1 JUVEDERM
10.1.2 SCULPTRA
10.1.3 RADIESSE
10.1.4 RESTYLANE
10.1.5 ZYPLAST
10.1.6 BELLAFILL
10.1.7 PURAGEN
10.1.8 ELEVESS
10.1.9 OTHERS
10.2 DIRECT PATIENT
11 GLOBAL FACIAL AESTHETICS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ANTI-AGING AND WRINKLES
11.3 FACIAL LINE CORRECTION
11.4 LIP AUGMENTATION
11.5 FACE LIFT
11.6 ACNE SCAR TREATMENT
11.7 CHEEK DEPRESSION
11.8 RECONSTRUCTIVE
11.9 OTHERS
12 GLOBAL FACIAL AESTHETICS MARKET, BY GENDER
12.1 OVERVIEW
12.2 MALE
12.3 FEMALE
13 GLOBAL FACIAL AESTHETICS MARKET, BY PROCEDURE
13.1 COSMETIC PROCEDURES
13.2 RECONSTRUCTION PROCEDURES
14 GLOBAL FACIAL AESTHETICS MARKET, BY ROUTE OF ADMINISTRATION
14.1 OVERVIEW
14.2 INTRADERMAL
14.3 SUBDERMAL
14.4 SUBCUTANEOUS
15 GLOBAL FACIAL AESTHETICS MARKET, BY END USER
15.1 OVERVIEW
15.2 COSMETIC CENTERS
15.3 DERMATOLOGY CLINICS
15.4 HOSPITALS
15.5 MEDICAL SPAS AND BEAUTY CENTERS
15.6 OTHERS
16 GLOBAL FACIAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.3.1 HOSPITAL PHARMACY
16.3.2 RETAIL PHARMACY
16.3.3 ONLINE PHARMACIES
17 GLOBAL FACIAL AESTHETICS MARKET, BY REGION
17.1 GLOBAL FACIAL AESTHETICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
17.2 NORTH AMERICA
17.2.1 U.S.
17.2.2 CANADA
17.2.3 MEXICO
17.3 EUROPE
17.3.1 GERMANY
17.3.2 FRANCE
17.3.3 U.K.
17.3.4 ITALY
17.3.5 SPAIN
17.3.6 RUSSIA
17.3.7 TURKEY
17.3.8 BELGIUM
17.3.9 NETHERLANDS
17.3.10 SWITZERLAND
17.3.11 REST OF EUROPE
17.4 ASIA-PACIFIC
17.4.1 JAPAN
17.4.2 CHINA
17.4.3 SOUTH KOREA
17.4.4 INDIA
17.4.5 AUSTRALIA
17.4.6 SINGAPORE
17.4.7 THAILAND
17.4.8 MALAYSIA
17.4.9 INDONESIA
17.4.10 PHILIPPINES
17.4.11 REST OF ASIA-PACIFIC
17.5 SOUTH AMERICA
17.5.1 BRAZIL
17.5.2 ARGENTINA
17.5.3 REST OF SOUTH AMERICA
17.6 MIDDLE EAST AND AFRICA
17.6.1 SOUTH AFRICA
17.6.2 SAUDI ARABIA
17.6.3 UAE
17.6.4 EGYPT
17.6.5 ISRAEL
17.6.6 REST OF MIDDLE EAST AND AFRICA
17.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
18 GLOBAL FACIAL AESTHETICS MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: GLOBAL
18.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
18.3 COMPANY SHARE ANALYSIS: EUROPE
18.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
18.5 MERGERS & ACQUISITIONS
18.6 NEW PRODUCT DEVELOPMENT & APPROVALS
18.7 EXPANSIONS
18.8 REGULATORY CHANGES
18.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
19 GLOBAL FACIAL AESTHETICS MARKET, SWOT AND DBMR ANALYSIS
20 GLOBAL FACIAL AESTHETICS MARKET, COMPANY PROFILE
20.1 ALLERGAN
20.1.1 COMPANY OVERVIEW
20.1.2 REVENUE ANALYSIS
20.1.3 GEOGRAPHIC PRESENCE
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 LUMINERA
20.2.1 COMPANY OVERVIEW
20.2.2 REVENUE ANALYSIS
20.2.3 GEOGRAPHIC PRESENCE
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.3 MEDYTOX
20.3.1 COMPANY OVERVIEW
20.3.2 REVENUE ANALYSIS
20.3.3 GEOGRAPHIC PRESENCE
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENTS
20.4 GALDERMA
20.4.1 COMPANY OVERVIEW
20.4.2 REVENUE ANALYSIS
20.4.3 GEOGRAPHIC PRESENCE
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 LABORATOIRE VIVACY SAS
20.5.1 COMPANY OVERVIEW
20.5.2 REVENUE ANALYSIS
20.5.3 GEOGRAPHIC PRESENCE
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENTS
20.6 CYNOSURE
20.6.1 COMPANY OVERVIEW
20.6.2 REVENUE ANALYSIS
20.6.3 GEOGRAPHIC PRESENCE
20.6.4 PRODUCT PORTFOLIO
20.6.5 RECENT DEVELOPMENTS
20.7 CUTERA
20.7.1 COMPANY OVERVIEW
20.7.2 REVENUE ANALYSIS
20.7.3 GEOGRAPHIC PRESENCE
20.7.4 PRODUCT PORTFOLIO
20.7.5 RECENT DEVELOPMENTS
20.8 ADVANCED DERMATOLOGY AND COSMETIC SURGERY
20.8.1 COMPANY OVERVIEW
20.8.2 REVENUE ANALYSIS
20.8.3 GEOGRAPHIC PRESENCE
20.8.4 PRODUCT PORTFOLIO
20.8.5 RECENT DEVELOPMENTS
20.9 MERZ PHARMACEUTICALS
20.9.1 COMPANY OVERVIEW
20.9.2 REVENUE ANALYSIS
20.9.3 GEOGRAPHIC PRESENCE
20.9.4 PRODUCT PORTFOLIO
20.9.5 RECENT DEVELOPMENTS
20.1 SANOFI-AVENTIS U.S. LLC
20.10.1 COMPANY OVERVIEW
20.10.2 REVENUE ANALYSIS
20.10.3 GEOGRAPHIC PRESENCE
20.10.4 PRODUCT PORTFOLIO
20.10.5 RECENT DEVELOPMENTS
20.11 BIOHA LABORATORIES
20.11.1 COMPANY OVERVIEW
20.11.2 REVENUE ANALYSIS
20.11.3 GEOGRAPHIC PRESENCE
20.11.4 PRODUCT PORTFOLIO
20.11.5 RECENT DEVELOPMENTS
20.12 DR.TWL DERMACEUTICALS
20.12.1 COMPANY OVERVIEW
20.12.2 REVENUE ANALYSIS
20.12.3 GEOGRAPHIC PRESENCE
20.12.4 PRODUCT PORTFOLIO
20.12.5 RECENT DEVELOPMENTS
20.13 ANIKA THERAPEUTICS, INC.
20.13.1 COMPANY OVERVIEW
20.13.2 REVENUE ANALYSIS
20.13.3 GEOGRAPHIC PRESENCE
20.13.4 PRODUCT PORTFOLIO
20.13.5 RECENT DEVELOPMENTS
20.14 ZIMMER AESTHETICS
20.14.1 COMPANY OVERVIEW
20.14.2 REVENUE ANALYSIS
20.14.3 GEOGRAPHIC PRESENCE
20.14.4 PRODUCT PORTFOLIO
20.14.5 RECENT DEVELOPMENTS
20.15 TEOXANE
20.15.1 COMPANY OVERVIEW
20.15.2 REVENUE ANALYSIS
20.15.3 GEOGRAPHIC PRESENCE
20.15.4 PRODUCT PORTFOLIO
20.15.5 RECENT DEVELOPMENTS
20.16 BOHUS BIOTECH AB
20.16.1 COMPANY OVERVIEW
20.16.2 REVENUE ANALYSIS
20.16.3 GEOGRAPHIC PRESENCE
20.16.4 PRODUCT PORTFOLIO
20.16.5 RECENT DEVELOPMENTS
20.17 AQUAMID
20.17.1 COMPANY OVERVIEW
20.17.2 REVENUE ANALYSIS
20.17.3 GEOGRAPHIC PRESENCE
20.17.4 PRODUCT PORTFOLIO
20.17.5 RECENT DEVELOPMENTS
20.18 ADODERM GMBH
20.18.1 COMPANY OVERVIEW
20.18.2 REVENUE ANALYSIS
20.18.3 GEOGRAPHIC PRESENCE
20.18.4 PRODUCT PORTFOLIO
20.18.5 RECENT DEVELOPMENTS
20.19 SINCLAIR PHARMA
20.19.1 COMPANY OVERVIEW
20.19.2 REVENUE ANALYSIS
20.19.3 GEOGRAPHIC PRESENCE
20.19.4 PRODUCT PORTFOLIO
20.19.5 RECENT DEVELOPMENTS
20.2 SUNEVA MEDICAL
20.20.1 COMPANY OVERVIEW
20.20.2 REVENUE ANALYSIS
20.20.3 GEOGRAPHIC PRESENCE
20.20.4 PRODUCT PORTFOLIO
20.20.5 RECENT DEVELOPMENTS
20.21 CROMA-PHARMA GMBH
20.21.1 COMPANY OVERVIEW
20.21.2 REVENUE ANALYSIS
20.21.3 GEOGRAPHIC PRESENCE
20.21.4 PRODUCT PORTFOLIO
20.21.5 RECENT DEVELOPMENTS
20.22 HUMEDIX.CO.LTD (A SUBSIDIARY OF HUONS ASIA-PACIFIC)
20.22.1 COMPANY OVERVIEW
20.22.2 REVENUE ANALYSIS
20.22.3 GEOGRAPHIC PRESENCE
20.22.4 PRODUCT PORTFOLIO
20.22.5 RECENT DEVELOPMENTS
20.23 SCULPT LUXURY DERMAL FILLERS LTD
20.23.1 COMPANY OVERVIEW
20.23.2 REVENUE ANALYSIS
20.23.3 GEOGRAPHIC PRESENCE
20.23.4 PRODUCT PORTFOLIO
20.23.5 RECENT DEVELOPMENTS
20.24 ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO.,LTD
20.24.1 COMPANY OVERVIEW
20.24.2 REVENUE ANALYSIS
20.24.3 GEOGRAPHIC PRESENCE
20.24.4 PRODUCT PORTFOLIO
20.24.5 RECENT DEVELOPMENTS
20.25 ORTHO DERMATOLOGICS
20.25.1 COMPANY OVERVIEW
20.25.2 REVENUE ANALYSIS
20.25.3 GEOGRAPHIC PRESENCE
20.25.4 PRODUCT PORTFOLIO
20.25.5 RECENT DEVELOPMENTS
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUESTRELATED REPORTS
21 CONCLUSION
22 QUESTIONNAIRE
23 ABOUT DATA BRIDGE MARKET RESEARCH
